Navigation Links
BioMS Medical to present at Sachs Associates Biotech in Europe Forum
Date:9/19/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, Sept. 19 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Tony Hesby, Executive Vice President, Corporate Affairs, will present at the Sachs Associates 8th Annual Biotech in Europe Investor Forum in Zurich, Switzerland.

WHEN: Tuesday September 23rd at 11:25am (Local Time)

WHERE: Zurich, Switzerland

About Sachs Associates Biotech in Europe Investor Forum

-------------------------------------------------------

The forum is recognized as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and listed companies with leading investors, analysts, money managers and pharmas.

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide (MBP8298), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide (MBP8298), in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Mechanicsburg, PA (PRWEB) May 17, 2013 ... with ramp/soak capabilities. The 5R6-900 temperature controller has many ... can be plugged into the wall as a self-contained ... power supply. This distinctive detail makes the device unique, ... , The controller can also be used universally, which ...
(Date:5/17/2013)... May 17, 2013 - Elsevier, a world-leading provider of ... announced the publication of a recent study in ... human blastocysts showing that those with an abnormal chromosomal ... they have developed to blastocysts, thereby classifying the risk ... study the same group has undertaken a retrospective study, ...
(Date:5/17/2013)... -- New interactive learning forums will ... of the medical device industry at the 2013 ... from June 18-20 in Philadelphia ... ) , These all-new MedTech Innovate ... presentations and implementable solutions on the most cutting-edge ...
(Date:5/17/2013)... JOSE, Calif. , May 17, 2013 /PRNewswire-iReach/ ... agreement has been reached with Switzerland ... portfolio of anti-infective human monoclonal antibody (mAb) products, ... anti-infective human mAb products for treatment of infections ... of Staphylococcus aureus , Pseudomonas aeruginosa ...
Breaking Biology Technology:New Temperature Control Products Announced by Oven Industries Inc. 2Breakthrough for IVF? 2Breakthrough for IVF? 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... that a new market research report is available in ... Agreements http://www.reportlinker.com/p0471283/Biomarker-Partnering-Terms-and-Agreements.html ... and Agreements report provides comprehensive understanding and unprecedented access ... by the worlds leading healthcare companies. * ...
... for the future of industrial catalysis, as well ... as artificial photosynthesis, researchers with the U.S. Department ... Lab) have created bilayered nanocrystals of a ,metal-metal ... catalytic sites on nanocrystal interfaces. These multiple catalytic ...
... 2011 Tomophase Corporation, a leading developer of minimally ... today that it has installed the first of its ... Medical Branch (UTMB) in Galveston, Texas. This ... the laboratory of Dr. Massoud Motamedi, Director, Center for ...
Cached Biology Technology:Reportlinker Adds Biomarker Partnering Terms and Agreements 2Reportlinker Adds Biomarker Partnering Terms and Agreements 3Reportlinker Adds Biomarker Partnering Terms and Agreements 4Reportlinker Adds Biomarker Partnering Terms and Agreements 5Reportlinker Adds Biomarker Partnering Terms and Agreements 6Reportlinker Adds Biomarker Partnering Terms and Agreements 7Reportlinker Adds Biomarker Partnering Terms and Agreements 8Berkeley Lab researchers report tandem catalysis in nanocrystal interfaces 2Berkeley Lab researchers report tandem catalysis in nanocrystal interfaces 3Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas 2
(Date:5/18/2013)... 18, 2013) Research presented at Digestive Disease ... health through diet and lifestyle. , Individuals ... reduced muscle strength, fatigue and poor quality of ... are in remission. A randomized, double blind, placebo-controlled ... D supplementation corresponded to significant relief of these ...
(Date:5/17/2013)... celebrate the science and technology of the region ... the inaugural Atlanta Science Festival, March 22-29, 2014. ... corporations, K-12 schools and universities, the festival will ... and adults at venues across the city. Learn ... annual Atlanta Science Festival is a collaboration of ...
(Date:5/17/2013)... The Federation of American Societies for Experimental Biology ... Institutes of Health (NIH) funding trends highlighting the devastating ... critical research. The FASEB analysis follows a May 15th ... MD, PhD, who testified that the $1.6 billion cut ... is "having a substantial impact on the scientific community." ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3First Atlanta Science Festival set for 2014 2
... This release is available in Spanish . ... are helping ensure that the smoked salmon that,s always a ... including among their achievements the development of a first-of-its-kind mathematical ... the optimal combination of temperature and concentrations of salt and ...
... at Houston (UTHealth) and BioHouston, Inc. on Oct. 21 ... entrepreneurs and new bio-tech start-ups in Houston. The ... nonprofits calls for greater collaboration between the organizations, technology ... saw the opportunity to expand wet lab facilities and ...
... are delivered head-first, but in about 4% of all ... or feet first. Doctors usually exercise caution and use ... for such births, believing it safer for the baby. ... the near-universal choice for such births. But now ...
Cached Biology News:USDA scientists helping keep in-demand smoked salmon safe to eat 2UTHealth, BioHouston sign collaborative agreement 2Breaching the breech protocol 2
Polaroid black & white positive, 3 x 4 inch pack film, ISO 3000/ 36 ASA DIN (20 expsures). For use in the Polaroid Direct Copy Camera (PHC34)....
Applications: (+) Immunocytochemistry and immunohistochemistry...
For the quantitative determination of canine Interferon gamma,(IFN-γ) concentrations in cell culture supernates, serum and,plasma....
Non-Protein Peroxidase Stabilizer , 1 L...
Biology Products: